🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#LEAD2024 with Dr Christine Garcia from Cornell who have an amazing update on Lung Cancer!

Thanks so much to my amazing co-chairs of the ⁦Ana I. Velázquez Mañana, MD, MSc, FASCO⁩ & Katie Lai! Thx for making #LEAD2024 awesome! Thx to our many great faculty & our attendees! Can’t wait till next year❤️

In early-stage NSCLC 🫁 IO is a reality with several approvals by FDA/EMA 👏🏻. ADJ trials with IO « more controversial » , Hwv, neoadj and periop CT+O trials more consistent results. Are we sure periop IO is better than only induction CT+IO in OS? Overtreating 🫁 w/pCR? #ILCS24

Congratulations to all the awardees! Dr. Julie Deutsch will be studying the application of Astropath and multiplex immunofluorescence to neoadjuvant lung cancer samples Johns Hopkins Thoracic Oncology LUNGevity Foundation Johns Hopkins Kimmel Cancer Center #lcsm

What a way to kick off#winterlung in sunny Fl! Our esteemed colleagues Dr Patricia Rivera and Dr Lecia Sequist ⁦Lecia Sequist, MD, MPH⁩ talking about Lung Cancer Screening. Thank you!!!

#WLC25 Great welcoming M. Patricia Rivera and Lecia Sequist, MD, MPH to Miami 🌴 during the #WinterLungConference and thank both of them for all their mentoring and work to overcome barriers to #lungcancerscreening with Coral Olazagasti, MD Sylvester Comprehensive Cancer Center #lcsm PER

Great way to start the day at #WLC25 with an amazing panel! Thank you! Congrats!

Bruna Pellini, MD discusses BRAF mutations at #WLC25 PER

#WLC25 Excellent case presented by Coral Olazagasti, MD Sylvester Comprehensive Cancer Center discussing ALK+ #lungcancer primary resistance to ALK TKIs and what to do when our usual therapies stop working. Key points : -repeat biopsies and NGS is 🔑 -refer to clinical trials early -discuss palliative care

Excellent debate at #WLC25 by ⁦Susan Combs Scott, MD⁩ and ⁦Balazs Halmos⁩ both deserved a trophy but Dr Scott delivered the knockout!

#WLC25 Susan Combs Scott, MD Johns Hopkins Thoracic Oncology knocked it out of the park⚾️🏟️winning 🥇argument that osimertinib monotherapy is no longer the 2025 standard for 1L EGFR+ NSCLC (highlighting FLAURA2 & MARIPOSA trials) EGFR Resisters #lcsm PER

#TTLC25 and ⁦Johns Hopkins Thoracic Oncology⁩ ⁦Kristen A. Marrone, MD⁩ ⁦Vincent Lam⁩ and Christine Hann!

Do you have advanced non-small cell #LungCancer and are aged 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: Efrat Dotan MD Carolyn Presley, MD MHS Balazs Halmos

Shout out to all women in International Women’s Day! You make this world a better place! Kristen A. Marrone, MD Susan Combs Scott, MD Elsa Anagnostou Christine Hann and Joy Feliciano Johns Hopkins Thoracic Oncology

The 3rd annual, IASLC endorsed #TexasLung25 is right around the corner! With 80+ leading national experts and community oncologists, this 2-day CE-accredited conference will equip HCPs with actionable insights for advancing #lungcancer care. Register now: hubs.ly/Q0393vxk0

Alittle Blake is all one needs

#TexasLung25 Women in Thoracic Oncology breakfast with great leaders discussing their career paths to leadership: ➡️Choosing your focus ➡️Overcoming Challenges ➡️Pivoting & embracing opportunity Dr. Julie Brahmer Karen Kelly Narjust Florez, MD, FASCO Loretta Erhunmwunsee, MD, FACS Mara Antonoff, MD, FACS #lcsm

💥 Tarlatamab improves survival in 2nd line SCLC. DeLLphi-304 results demonstrated statistical significant and clinically meaningful improvement in overall survival compared to standard of care chemotherapy. #LCSM ⁦SmallCellSMASHERS⁩ investors.amgen.com/news-releases/…

At #TLC25 listening to amazing ⁦Jill Feldman⁩ quite the Eras tour!

#ecogacrinspring2025 awesome colleagues and fantastic group!